1. Anti-angiogenic therapies in brain metastases
   Anna S. Berghoff et al, 2018, memo - Magazine of European Medical Oncology CrossRef
2. Anti-angiogenics in Brain Metastases: Perspectives and Experiences
   Frank Winkler, 2019, Tumor Angiogenesis CrossRef
3. First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis
   Chu Zhang et al, 2020, Medicine CrossRef
4. Bevacizumab for non-small cell lung cancer patients with brain metastasis: A meta-analysis
   Ping Liang et al, 2020, Open Medicine CrossRef
5. MODERN IDEAS ABOUT THE COMBINATION OF RADIATION THERAPY WITH ANTIANGIOGENIC DRUGS IN THE TREATMENT OF PATIENTS WITH BRAIN METASTASES
   O. I. Kit et al, 2020, Siberian journal of oncology CrossRef
6. Newly developed anti-angiogenic therapy in non-small cell lung cancer
   Jingjing Qu et al, 2018, Oncotarget CrossRef
7. Effect of pemetrexed on brain metastases from nonsmall cell lung cancer with wild-type and unknown EGFR status
   Xiaoqing Yu et al, 2019, Medicine CrossRef
8. Antiangiogenics in Brain Metastases: Perspectives and Experiences
   Frank Winkler, 2019, Tumor Angiogenesis CrossRef
9. Combinatorial treatment using bevacizumab/pemetrexed loaded core-shell silica nanoparticles for non-small cell lung cancer
   Deepika Radhakrishnan et al, 2023, Science and Technology of Advanced Materials CrossRef